Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00219999 · ClinicalTrials.gov registry record
Hepatitis C Virus and the Humoral Immune System
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 161
- Enrollment target
NCT00219999 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 161 participants.
The verdict
NCT00219999 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 161 participants
- Enrollment target
Study Summary
The purpose of this study is to measure specific chemokines, antibodies, and antibody-producing B cells in the blood of patients with hepatitis C virus (HCV) infection. Our hypothesis is that changes in chemokine levels affect the development of an effective immune response against HCV.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2001-09 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00219999
The ClinicalTrials.gov registry entry for NCT00219999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00219999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00219999 about?
NCT00219999 is a clinical study titled "Hepatitis C Virus and the Humoral Immune System". The purpose of this study is to measure specific chemokines, antibodies, and antibody-producing B cells in the blood of patients with hepatitis C virus (HCV) infection. Our hypothesis is that changes in chemokine levels affect the development of an effective immune response against HCV.
What is the current status of trial NCT00219999?
This trial is currently completed. The enrollment target is 161 participants. The study started on 2001-09. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT00219999?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.